Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q3 2025 Earnings Call Transcript

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q3 2025 Earnings Call Transcript November 4, 2025

Madrigal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-5.08 EPS, expectations were $-2.03702.

Operator: Good morning, and thank you for standing by. Welcome to the Madrigal Pharmaceuticals Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today’s conference call is being recorded. I’d now like to introduce Ms. Tina Ventura, Chief Investor...